CARIS LIFE SCIENCES, INC. Costs and Expenses
CARIS LIFE SCIENCES, INC. (CAI) reported Costs and Expenses of $236.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. costs and expenses for the quarter ending 2026-06-30 was $236.79M, a 18.76% increase year-over-year.
- CARIS LIFE SCIENCES, INC. costs and expenses for the quarter ending 2026-03-31 was $210.89M, a 17.90% increase year-over-year.
- CARIS LIFE SCIENCES, INC. costs and expenses for the quarter ending 2025-12-31 was $204.47M, a 22.47% increase year-over-year.
- CARIS LIFE SCIENCES, INC. costs and expenses for the quarter ending 2025-09-30 was $184.19M, a 13.37% increase year-over-year.
- CARIS LIFE SCIENCES, INC. costs and expenses for fiscal 2025 was $766.92M, a 14.57% increase from fiscal 2024.
- CARIS LIFE SCIENCES, INC. costs and expenses for fiscal 2024 was $669.38M, a 6.98% increase from fiscal 2023.
- CARIS LIFE SCIENCES, INC. costs and expenses for fiscal 2023 was $625.68M.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $236.79M 10-Q · filed 2026-08-05 | $447.68M 10-Q · filed 2026-08-05 | $652.15M derived: sum of 3 quarters · filed 2026-08-05 | $836.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $210.89M 10-Q · filed 2026-05-08 | $415.37M derived: sum of 2 quarters · filed 2026-05-08 | $599.56M derived: sum of 3 quarters · filed 2026-05-08 | $798.95M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $204.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $388.67M derived: sum of 2 quarters · filed 2026-03-03 | $588.05M derived: sum of 3 quarters · filed 2026-08-05 | $766.92M 10-K · filed 2026-03-03 |
| 2025-09-30 | $184.19M 10-Q · filed 2025-11-05 | $383.58M derived: sum of 2 quarters · filed 2026-08-05 | $562.45M 10-Q · filed 2025-11-05 | $729.41M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $199.39M 10-Q · filed 2026-08-05 | $378.25M 10-Q · filed 2026-08-05 | $545.22M derived: sum of 3 quarters · filed 2026-08-05 | $707.68M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $178.87M 10-Q · filed 2026-05-08 | $345.83M derived: sum of 2 quarters · filed 2026-05-08 | $508.29M derived: sum of 3 quarters · filed 2026-05-08 | $675.35M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $166.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $329.42M derived: sum of 2 quarters · filed 2026-03-03 | $496.48M derived: sum of 3 quarters · filed 2026-03-03 | $669.38M 10-K · filed 2026-03-03 |
| 2024-09-30 | $162.46M 10-Q · filed 2025-11-05 | $329.52M derived: sum of 2 quarters · filed 2025-11-05 | $502.42M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $167.06M 10-Q · filed 2025-08-12 | $339.96M 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | $625.68M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |